Skip to content

The Easibility and Safety of Transabdominal Laparoscopic Single Incision Plus One Port Synchronous Combined With Transanal Total Mesorectal Excision Assisted by Da Vinci Robot for Low Rectal Carcinoma

The Easibility and Safety of Transabdominal Laparoscopic Single Incision Plus One Port Synchronous Combined with Transanal Total Mesorectal Excision Assisted by Da Vinci Robot for Low Rectal Carcinoma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026942
Enrollment
Unknown
Registered
2019-10-27
Start date
2019-10-28
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Carcinoma

Interventions

1:R-TaTME
2:SIPOP-R-TaTME

Sponsors

Army Characteristic Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. rectal cancer patients, confirmed by the endoscopic biopsy; 2. curative rectal cancer in clinical stage with resectable lesion, the cTNM stage <= T3 stage, with comparable tumor size in low or medial rectum. 3. patients' general information, 18ys<age<75ys, no restriction in genders, BMI< or = 30kg/m2, no presentation of severe chronic diseases (i.e. COPD), WHO classification <2 (Zubrod-ECOG-WHO). 4. patients or representatives have agreed and signed the informed consent documents.

Exclusion criteria

Exclusion criteria: 1. previous surgery in pelvis uncontrollable diseases such as diseases in cardiopulmonary function, chronic bronchitis, severe hepatitis/diabetes/malnutrition/renal function. 2. suffer from other malignant diseases, i.e. gastric cancer, liver cancer. 3. pregnant, lactation stage. 4. metal disorders. 5. lacking qualified compliance.

Design outcomes

Primary

MeasureTime frame
1. Operative time, 2. Intraoperative blood loss, 3.number of lymph nodes harvested, 4.Mesangial integrity;

Secondary

MeasureTime frame
1.Anastomotic fistula 2. Infection before sacral cavity and abdominal cavity 3. Postoperative bleeding 4. Intestinal obstruction 5. Urinary retention 6.30-day readmission rate;

Countries

China

Contacts

Public ContactLi Fan

Army Characteristic Medical Center

levinecq@163.com+86 18696539200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026